Lepto 4 + Dappv

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Lepto 4 + Dappv

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 12

Most Affected Breeds

Beagle 2

Retriever - Labrador 2

Collie (unspecified) 1

Schnauzer - Miniature 1

Catahoula Leopard Dog 1

Shepherd Dog - German 1

Sheepdog - Shetland 1

Dachshund (unspecified) 1

Greyhound 1

Spitz - German Pomeranian 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 4

Vomiting 4

Seizure NOS 3

Face and neck swelling (see also 'Skin') 1

Rubbing 1

Injection site itching 1

Itching 1

Weak pulse 1

Tachycardia 1

Anaphylaxis 1

Erythema (for urticaria see Immune SOC) 1

Facial oedema 1

Outcome Breakdown

Ongoing

6 (50.0%)

Recovered/Normal

6 (50.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.